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Abstract
Background: The human GLB1 gene is known to give rise to two alternatively spliced mRNAs,
which encode two different proteins: lysosomal β-galactosidase (β-gal) and elastin-binding protein
(EBP). The β-gal transcript includes the 16 exons of the GLB1 gene. In the EBP transcript, exons 3,
4 and 6 are skipped, while exon 5 has a different reading frame. However, little is known on how
this alternative splicing is regulated.
Findings: Cycloheximide treatment of HeLa cells and human fibroblasts revealed the presence of
new transcripts that are otherwise degraded by nonsense-mediated decay (NMD). A minigene
carrying the exons involved in the alternative splicing of GLB1 was constructed. Improving the
acceptor-site scores of exons 3 or 4 increased the relative inclusion of these exons, but did not
stop them being skipped in some transcripts. Overexpression of different SR proteins altered the
relative proportion of the different transcripts produced by the minigene, indicating a possible
mechanism for the regulation of the alternative splicing of GLB1. Finally, a comparison of this gene
among different species was performed.
Conclusion: In the processing of the GLB1 RNA several transcripts are generated, but only those
with a correct reading frame are not degraded. The differential inclusion/exclusion of exons could
be partially explained by the relatively weak splice sites in the exons involved. Different SR proteins
have an effect on the process of skipping of these exons, at least in the minigene conditions,
indicating a possible mechanism for the regulation of the alternative splicing of the GLB1 gene.
Background
The existence of splicing in eukaryotic RNAs has been
known for more than 25 years [1,2]. Aternative splicing,
which may affect 30 to 70% of the genes in higher eukary-
otes [3,4], allows the generation of multiple transcripts by
different mechanisms such as exon skipping/inclusion,
alternative 5' or 3' splice sites, intron retention or mutu-
ally exclusive exons. Alternative exons often have subopti-
mal splice sites and/or suboptimal length when compared
with constitutive exons. Besides the proteins that are
present in constitutive splicing, a group of proteins that
bind to pre-mRNA sequences are also necessary in alterna-
tive splicing [5]. The sequences where these proteins bind
are called exonic or intronic enhancers (ESEs or ISEs) and
silencers (ESSs or ISSs). Most of the ESEs are recognized by
SR proteins. They constitute a family of proteins that has
an RS domain (rich in arginines and serines) and 1 or 2
RRM domains (RNA-binding domains) and are essential,
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some assembly and for alternative splicing [6]. On the
other hand, the best characterized ESSs and ISSs are recog-
nized by members of the heterogeneous nuclear ribonu-
cleoprotein (hnRNP) family, which are highly abundant
RNA-binding proteins that lack an RS domain [7]. It is
known that these proteins have a dose-dependent effect
and that the binding of SR and hnRNP proteins on the
pre-mRNA allows the splicing machinery to act in a tissue
or in a developmental stage specific manner [8].
Nonsense-mediated mRNA decay (NMD) is a well known
mechanism that degrades mRNAs harbouring premature
termination codons (PTCs), not only generated by de novo
nonsense mutations but also of those naturally found in
physiological transcripts [9]. Over recent years, the cou-
pling between NMD and alternative splicing has become
more evident [10].
The GLB1 gene (GenBank NM_000404.1), located on
chromosome 3 at 3p21.33 and organized into 16 exons,
is the gene coding for the β-galactosidase protein
(E.C.3.2.1.23) [11]. This enzyme cleaves terminal β-galac-
toses from different substrates in the lysosome. A second
transcript generated by alternative splicing was described
[12], but it was not until 10 years later that the protein
coded by this second transcript, the elastin-binding pro-
tein (EBP), was identified [13]. While the β-galactosidase
cDNA is 2.5 kb long, the second transcript is only 2 kb,
lacks exons 3, 4 and 6, and bears exon 5 in a different read-
ing frame. The amount of the 2-kb transcript was also
reported to be much lower (less than 1/10) than that of
the 2.5-kb transcript [12].
Mutations in the GLB1 gene that result in the absence or
reduced activity of the lysosomal enzyme β-galactosidase
produce two different diseases: GM1-gangliosidosis
(MIM# 230500) and Morquio B (MIM# 253010). A role
of EBP in these diseases has also been suggested but is still
under discussion [14,15].
Efforts have been made to establish the function and
interactions of both proteins. In contrast, no studies have
been reported on the way alternative splicing of the GLB1
gene is regulated. Here we present an attempt to establish
the mechanisms underlying this alternative splicing.
Methods
Vector construction, cell culture and transfection condi-
tions, and molecular biology techniques are provided [see
Additional file 1].
Endogenous transcript analysis
After treating cells with cycloheximide (CHX), besides the
β-Gal and EBP transcripts, other transcripts bearing differ-
ent combinations of exons 3, 4 and 6 were found. If these
transcripts were generated, they would bear PTCs, because
they would produce new reading frames (Figure 1a). RT-
PCR using an EBP-specific primer (Table 1) revealed the
presence of these intermediate transcripts in the CHX-
treated cells, as shown in Figure 1b and 1c. The experi-
ment was also performed on human control fibroblasts to
rule out a possible specific effect of the transformed HeLa
cell line. Again, bands corresponding to the intermediate
transcripts were observed, although their relative abun-
dance was different between the two cell types (Figure 1b,
c). Two primers that should not anneal to any of the two
natural transcripts were designed (2_4F and 4_6F). RT-
PCR using the 2_4F/C3R or the 4_6F/C3R primers on
cDNA from CHX-treated and untreated HeLa cells dis-
played a band only in the CHX-treated cells (data not
shown).
Minigene transcript analysis
In order to study GLB1 alternative splicing, a minigene
(BX) including the alternatively spliced region of the gene
(exons 2, 3, 4, 5, 6 and 7) was constructed (Figure 2a). The
BX minigene was made so that the different combination
of exons generated transcripts without PTCs. This allowed
us to completely discard the effect of NMD as the cause of
the observed pattern of bands.
To determine whether some of the missing intronic
sequences were essential for the correct splicing of any of
the cloned exons, the BX construct was transfected in
HeLa cells and RT-PCR was carried out using plasmid-spe-
cific primers (T7/SP6). A single band was obtained (data
not shown). Sequencing of this PCR product showed that
it corresponded to a transcript that included the 6 cloned
exons, indicating that the intron regions present in the BX
construct bore the necessary cis sequences for correct splic-
ing. If alternative splicing giving rise to the EBP transcript
was taking place, it was at a very low level (as in the endog-
enous splicing), since no band corresponding to this tran-
script was detected.
In order to check whether EBP-specific splicing occurred at
all, RT-PCR was performed with EBP-specific primers.
Both T7/EBPR and EBPF/SP6 pairs of primers produced a
PCR band corresponding to the EBP transcript. However,
the band corresponding to the EBP transcript was a minor
one and extra bands, corresponding to other intermediate
transcripts, were also observed. The BX lane in Figure 3a
shows the results for the T7/EBPR pair of primers. Similar
results were obtained for EBPF/SP6 (not shown).
Effect of exon 3 and exon 4 acceptor sites on alternative 
splicing
In silico analysis of the 3' splice sites (3'ss) of the GLB1
gene revealed a low score of 2.5 for the site flanking exonPage 2 of 9
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Different transcripts of the GLB1 geneFigu  1
Different transcripts of the GLB1 gene. (a) Scheme of the GLB1 gene. Different possible transcripts are shown. The prim-
ers used to amplify these transcripts are indicated by horizontal arrows. Black circles are natural stop codons whereas red cir-
cles indicate PTCs. (b) &(c) RT-PCR on cDNA from cycloheximide-treated (CHX) or not treated (NT) HeLa cells and human 
fibroblasts. The transcripts corresponding to each band are outlined on the right. (b) PCR using C1F/EBPR as primers. (c) PCR 
using EBPF/C3R as primers. * indicates bands for possible transcripts including only exon 3 or only exon 4.
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and a high score of 10 for exon 6 acceptor site, compared
to the average score of constitutive exons (7.9). To check
whether the skipping of exons 3 and 4 in the alternative
splicing was due to the weak acceptor sites, 2 positions on
each 3'ss were mutagenized in the BX minigene, generat-
ing the BX3 and BX4 constructs. These changes increased
the 3'ss scores on exons 3 and 4, from 6 to 9.5 and from
2.5 to 7, respectively (Figure 2a, b). Analysis of the tran-
scripts generated by these plasmids showed an increase of
the transcript including only exon 3 (BX3 lane) and of the
transcript including only exon 4 (BX4 lane), although the
transcripts lacking both exons were also observed (Figure
3a). Quantification of the transcripts bearing exon 3 (or
exon 4) versus transcripts lacking exon 3 (or exon 4),
showed small but significant increases. As expected, plas-
mid BX3 produced proportionally more transcripts bear-
ing exon 3 than BX (116%, Figure 3b), and plasmid BX4
produced more bearing exon 4 (120%, Figure 3c). It
should be noted that plasmid BX4 also produced more
transcripts bearing exon 3 than BX (124%), but this was
not significant. Nevertheless, the fact that some transcripts
with skipped exons 3 and/or 4 were still produced, sug-
gests that the weak 3' splice sites are not sufficient to
explain why these exons might be skipped.
Effect of over-expression of SR proteins on alternative 
splicing
To assess the effect of the SR and hnRNP A/B proteins on
GLB1 alternative splicing, HeLa cells were cotransfected
with the BX plasmid together with a plasmid expressing
one of the following proteins: SF2/ASF, SRp20, SRp40,
SRp55, 9G8 or hnRNPA1. The analysis was focused on the
inclusion/exclusion of exons 3 and 4. The different tran-
scripts detected by RT-PCR using primers T7/EBP_R were
quantified. Although none of these proteins could com-
pletely restore the inclusion of one of the exons (3 or 4),
important variations in the relative proportion between
the different transcripts were detected (Figure 4a–c). The
cotransfection of the BX plasmid plus an empty pcDNA3
plasmid was used as a control (BX lane). Quantification of
the bands showed that the SR proteins reduced the rela-
tive amount of the EBP transcript, compared to the tran-
script that includes all the exons. Additionally, most of the
SR proteins increased the amount of transcripts including
exons 3 or 4 (Figure 4b, c). This indicates a function for SR
proteins favouring the inclusion of these exons, although
Table 1: Primers and RT-PCR conditions
Primers employed in the RT-PCR RT-PCRs performed
Primer Sequence (5'->3') GLB1Exona Transcript specificity Pairs of primers employed AT (°C)
C1F ACTGCAGAGCCGGGAGGCTGGT 1 EBP/β-Gal C1F/EBPR 58
C3R CCAAAGTGACCTTTCCATATG 11 EBP/β-Gal EBPF/C3R 56.5
EBPF GGCTGAACGCCATCCAGACATT 2–5 EBP T7/SP6 55
EBPR TGATGTTGCTGCCTGCACTG 7–5 EBP T7/EBPR 56.5
2_4F ACGCCATCCAGACGGAGGAT 2–4 NN EBPF/SP6 58
4_6F TCCTCCGACCCAGGTTGAA 4–6 NN 2_4F/C3R 59
T7 TAATACGACTCACTATAGGG -- pcDNA3 2_4F/SP6 58.3
SP6 GATTTAGGTGACACTATAG -- pcDNA3 4_6F/C3R 59
C1Fm GAGACCCCATCGTGGCGCGA 1 m EBP/β-Gal C1Fm/C1Rm 59
C1Rm CTCTAGTAGCCAAGCAGGTAAGC 4 m β-Gal EBPFm/EBPRm 58
EBPFm GGGCTGAATGCTATCCAGATAC 2–5 m EBP
EBPRm TGTGATATTGTTGCCTGCACGGT 7–5 m EBP
AT: annealing temperature; NN: not naturally ocurring; m:mouse.
aGLB1 exon or exons that are complementary to the indicated primersPage 4 of 9
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exon 3 (SRp55 and SF2/ASF) or exon 4 (SRp20 and 9G8).
On the other hand, hnRNPA1, which has been reported to
inhibit splicing [7], here seems to favour the inclusion of
both exons too. However, an in vitro splicing enhance-
ment effect of hnRNPA1 has also been reported [16]. Pre-
vious studies have found a close similarity between the
RRMs of proteins 9G8 and SRp20, which can recognize
some identical sequences [17], and moreover, it has also
been reported that 9G8 can participate in splicing regula-
tion as a functional SRp20 homologue in certain condi-
tions [18]. In our study, both proteins produced the same
change of pattern (that is, favour the inclusion of exon 4),
consistent with these previous results.
To analyse whether the effect of the SR proteins was spe-
cific for exons 3 and 4 or if it was a general phenomenon,
a similar experiment was performed using the 2_4F/SP6
primers to measure the effect on the inclusion/exclusion
of exons 5 and 6 (Figure 5). The results showed again that
the SR proteins had a general effect of favouring the inclu-
sion of exons 5 and 6. The experiment was repeated three
times with similar results.
The differences in the pattern observed for each protein
may indicate their different roles in the constitutive and
alternative splicing of these exons. However, it should be
taken into account that the over-expression of the SR pro-
teins in the minigene experiments, which is far from being
a physiological situation, could alter the interactions
between the over-expressed and endogenous SR proteins.
Moreover, the characteristics of the minigene, such as the
type of promoter or the lack of some of the intronic
sequences, should also be considered.
GLB1 alternative splicing in other species
It had already been described that the EBP could not be
generated in mouse (Mus musculus) through the alterna-
tive splicing of the GLB1 gene, because the translation of
exon 5 in mouse is only possible in the reading frame that
codes for lysosomal β-galactosidase [19]. Analysis of the
GLB1 exon 5 sequences in different species showed that
this also happens in rat (Rattus norvegicus). However, in
BX minigene: mutated splice sites and scoresFigure 2
BX minigene: mutated splice sites and scores. (a) Scheme of the BX minigene construct. Exons: grey boxes. Introns: 
horizontal lines. Two lines cutting introns indicate that the whole intron was not cloned. The naturally occurring β-Gal (above 
the exons) and EBP (below the exons) splicing pathways are indicated. * (in red) indicates the location of the changes intro-
duced by site-directed mutagenesis in BX3 and BX4 constructs. Arrows indicate the location of T7 and SP6 primers. PCMV: 
CMV promotor; BGHpA: BGH polyadenylation site. (b) 3'ss wild-type and mutated sequences and calculated splicing scores. 
Changes introduced by mutagenesis are underlined. cons: plasmid construct.Page 5 of 9
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catus), crab-eating macaque (Macaca fascicularis) or rabbit
(Oryctolagus cuniculus) and also in birds such as the
chicken (Gallus gallus), both reading frames are possible.
Therefore, in all the species analyzed in silico, except for rat
and mouse, a reading frame where exons 3, 4 and 6 are
skipped is possible.
To see if the EBP alternative splicing (i.e. exclusion of
exons 3, 4 and 6) occurred in mice, RAW264.7 cells were
cultured in the presence and absence of CHX, and β-Gal-
and EBP-like-specific RT-PCR were carried out. The C1Fm/
C1Rm primers were used for β-Gal and the C1Fm/EBPRm
primers for EBP-like (Table 1). The EBP-like transcript was
detected only in the CHX-treated cells (data not shown).
The existence of this EBP-like transcript suggests that its
absence in rodents (Murinae) could be explained by the
presence of the PTC (a change that is synonymous in the
β-gal frame) and the corresponding degradation by NMD.
Semiquantitative RT-PCR on cDNA from transfected HeLa cells with plasmids BX, BX3 and BX4Figure 3
Semiquantitative RT-PCR on cDNA from transfected HeLa cells with plasmids BX, BX3 and BX4. (a) Semiquan-
titative RT-PCR using T7/EBPR primers (left) and scheme of the transcript corresponding to each band is shown (right). (b) 
Percentage of transcripts including exon 3 versus transcripts lacking it, i.e. (1+2)/(3+4). (c) Percentage of transcripts including 
exon 4 versus transcripts lacking it, i.e. (1+3)/(2+4). Each value is the mean ± S.E. of two independent experiments, each of 
which was replicated three times. * when p < 0.05.Page 6 of 9
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RT-PCR using primers T7/EBPR after cotransfection with the BX and SR plasmidsFigure 4
RT-PCR using primers T7/EBPR after cotransfection with the BX and SR plasmids. (a) Semiquantitative RT-PCR, 
using primers T7/EBPR, on cDNA from HeLa cells cotransfected with the BX plasmid together with a plasmid expressing one 
of the following proteins: SF2/ASF, SRp20, SRp40, SRp55, 9G8 and hnRNPA1. The BX lane is the control. The transcripts cor-
responding to each band are drawn on the right. (b) &(c) Quantification of radio-labelled RT-PCR for the different transcripts 
(b for transcripts including exon 3 versus transcripts lacking it, i.e. (1+2)/(3+4) and c for transcripts including exon 4 versus 
transcripts lacking it, i.e. (1+3)/(2+4)), considering BX transfection as 100% in each case. Each value is the mean ± S.E. of two 
independent experiments, each of which was replicated three times. * when p < 0.05.
BMC Research Notes 2008, 1:137 http://www.biomedcentral.com/1756-0500/1/137The question of which is the gene coding for the mouse
EBP protein, if it exists, or which protein performs a simi-
lar function, remains open.
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